Evidence check: VKORC1 in the context of longevity

The provided context contains no specific data or studies on VKORC1 in relation to longevity. VKORC1 encodes vitamin K epoxide reductase, a key enzyme in the vitamin K cycle, best known for its role in warfarin sensitivity. In longevity research, vitamin K is increasingly discussed for its role in activating matrix Gla protein (MGP) and inhibiting vascular calcification – a potential mechanism for cardiovascular health in aging. However, these links are based mostly on mechanistic and epidemiological data; robust GWAS or interventional studies directly associating VKORC1 variants with extended lifespan are lacking. The evidence is therefore rated as 'mechanistic' to 'unclear'. Without concrete lab results or clinical trials from the context, any claim remains speculative. Consumers should be aware that DNA tests for VKORC1 are primarily validated for pharmacogenetics (warfarin dosing), not for longevity prediction. Lifestyle factors (diet, exercise, stress management) currently have a far greater impact on healthy lifespan than single gene variants.